GRIPTIDE Trademark

Trademark Overview


On Friday, November 15, 2019, a trademark application was filed for GRIPTIDE with the United States Patent and Trademark Office. The USPTO has given the GRIPTIDE trademark a serial number of 88693694. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Fog Pharmaceuticals, Inc.. The GRIPTIDE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

biomedical compounds for medical purposes, namely, amino acids, peptides, stapled peptides, and synthetic peptides, in particular amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions

Biomedical compounds, namely, amino acids; biomedical compounds, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for use in scientific and laboratory research; biomedical compounds, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) in raw material form for use in scientific and laboratory research
griptide

General Information


Serial Number88693694
Word MarkGRIPTIDE
Filing DateFriday, November 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Goods and Servicesbiomedical compounds for medical purposes, namely, amino acids, peptides, stapled peptides, and synthetic peptides, in particular amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
Pseudo MarkGRIP TIDE
Goods and ServicesBiomedical compounds, namely, amino acids; biomedical compounds, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for use in scientific and laboratory research; biomedical compounds, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) in raw material form for use in scientific and laboratory research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePARABILIS MEDICINES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Tuesday, November 19, 2019NEW APPLICATION ENTERED
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 31, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021SOU EXTENSION 1 FILED
Thursday, April 22, 2021SOU EXTENSION 1 GRANTED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 15, 2021SOU EXTENSION 2 FILED
Friday, October 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 25, 2022SOU EXTENSION 3 FILED
Monday, April 25, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 5, 2022SOU EXTENSION 4 FILED
Wednesday, October 5, 2022SOU EXTENSION 4 GRANTED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 12, 2023SOU EXTENSION 5 FILED
Monday, April 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 17, 2023SOU EXTENSION 5 GRANTED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP